Purpose of review In ICU patients, dyspnea is one of the most prominent and distressing symptom. We sought to summarize current data on the prevalence and prognostic influence of dyspnea in the ICU setting and to provide concise and useful information for dyspnea detection and management.
INTRODUCTION
Over the past decade, growing attention has been given to the detection and treatment of pain in ICU patients. Interestingly, during the same period, very little attention has been given to dyspnea. Indeed, data regarding dyspnea in ICU patients are scarce and there are basically no recommendations regarding the assessment and the management of dyspnea in ICU patients. Beyond being a major source of discomfort, dyspnea shares many physiological and clinical features with pain. This should make it a major preoccupation for ICU physicians and nurses whose mission is to relieve symptoms in addition to treating disease processes. However, it might be a challenging issue in mechanically ventilated patients whose ability to communicate is limited.
The objective of the present review is to provide information regarding the prevalence and the risk factors of dyspnea in mechanically ventilated ICU patients. It is also to suggest some approaches to detect, quantify and manage dyspnea in these patients.
PREVALENCE OF DYSPNEA
Dyspnea is the subjective experience of breathing discomfort. As a result, dyspnea should be selfreported by the patient [1] . Although respiratory distress is generally associated with dyspnea, a patient may experience dyspnea without exhibiting objective respiratory signs, rendering its detection sometimes complex [2] .
In unselected nonintubated critically ill patients, dyspnea assessed by visual analogic scale [D-VAS, ranging from 0 (no dyspnea) to 10 (worst possible dyspnea)] appears to be frequent (circa 50%) and severe [median (IQR) of 4.5 (3.2-6.0)] [3] [4] [5] . Whereas mechanical ventilation is supposed to alleviate dyspnea caused by acute respiratory failure (ARF), the prevalence of dyspnea among intubated patients remains similar (circa 50%) [6, 7, 8 & ], with the same 'moderate-to-severe' intensity [median D-VAS, 5 (4-7)]. In patients receiving noninvasive ventilation (NIV) as first line treatment for ARF, 55% present a moderate-to-severe dyspnea before NIV initiation and 39% after the first NIV session [9 && ].
CLINICAL RELEVANCE OF DYSPNEA
There is growing evidence suggesting that dyspnea has a deleterious impact on mechanically ventilated patients. The consequences of dyspnea may occur either immediately during the ICU stay or be delayed.
Immediate suffering
Patients with lung cancer presenting dyspnea have reported terrifying feelings such as: 'it's a feeling... you're going to die because you're not getting enough air'; 'if I felt I had to live my life feeling like that I would jump out the window' [10] . With visual analogic scale (VAS) ratings of at least four in most of cases, dyspnea appeared to qualify as 'moderate to intense' [6] . Similar pain ratings are an indication for analgesia.
In addition, in mechanically ventilated patients, dyspnea is independently and strongly associated with anxiety [6] . This is not surprising as the interplay between anxiety and dyspnea is complex and causative relationships can exist in both directions. Anxiety-relieving interventions could, thus have a positive effect on respiratory rhythm and anxiety decreases in patients who reported improvements of dyspnea after adjustments of the ventilator settings [6] .
Impact on outcomes
In addition to the burden that it represents for the patients that it afflicts, dyspnea is also a marker of a worse prognosis [11] . Indeed, in patients with respiratory or cardiac disorders, dyspnea is strongly associated with reduced life expectancy [12, 13] .
In intubated patients, persistent dyspnea despite an optimization of ventilator settings is associated with delayed extubation [6] . In addition, the median intensity of dyspnea at the end of a spontaneous breathing trial (SBT) is higher in patients who fail than in those who succeed the SBT [14] . However, whether the presence of dyspnea or its intensity is associated with a higher mortality in intubated patients is not demonstrated [6] . Data from a recently completed multicenter observational study (NCT02336464) may address this question. In patients receiving NIV, the persistence of a moderate-to-severe dyspnea after the first NIV session is independently associated with NIV failure and mortality [9 && ].
Delayed impact of dyspnea
Patients' recollections of their ICU experience point to dyspnea during mechanical ventilation as a major ICU stressor [15, 16] . Dark 'respiratory recollections' may persist for several weeks. When questioned 2-48 months after discharge, 47% of patients who had been mechanically ventilated during ICU stay reported having felt anxiety and/or fear during mechanical ventilation [17] .
Post-Traumatic Stress Disorder (PTSD) is now recognized as a common sequel of the ICU experience [18] . Recalled dyspnea is associated with posttraumatic stress (PTSD) in ICU survivors [18] and PTSD symptom scores in the post-ICU population are significantly correlated with duration of mechanical ventilation [19] .
DETECTION OF DYSPNEA
As is the case with pain, assessment of dyspnea depends on self-report, which requires the patient to be communicative. In case, the patient is not, surrogates will be used. Figure 1 proposes an algorithm for dyspnea assessment in the critically or terminally ill patients.
KEY POINTS
In intubated patients, dyspnea is frequent, severely distressing and associated with poorer outcomes.
Dyspnea assessment remains challenging in intubated patients and one-third miss its evaluation because of impaired self-report abilities.
Heteroevaluation scales are promising alternatives to self-report making breathing discomfort evaluation possible in noncommunicative patients.
Communicative patients: the self-report approach
Unidimensional tools: measure dyspnea intensity Self-evaluation of dyspnea requires to ensure the patient is able to report dyspnea, to assess the presence or absence of dyspnea and if dyspnea is present, to quantify its intensity.
In order to self-report dyspnea, the patient must be conscious and able to interpret sensory stimuli [20] . Clinical practice shows that conscious mechanically ventilated patients are generally able to answer simple questions about their respiratory sensations.
There is no clear criterion to attest that a patient is communicative. In a pragmatic approach, a reasonable awareness defined by Richmond Agitation and Sedation Scale score [21] between À2 and þ2 associated with the absence of delirium according to the Confusion Assessment Method for the ICU (CAM-ICU) [22] are acceptable prerequisite.
The following step is to detect the presence of dyspnea by dichotomic simple questions such as 'do you breathe well,' 'is your breathing comfortable,' 'are you bothered by your breathing,' 'is your breathing difficult' and ensure that answers are concordant between at least two questions [1] .
The last step is to measure the intensity of the dyspnea. Although more than 40 tools exist to assess FIGURE 1. Neurophysiological mechanisms of dyspnea: imbalance between corollary discharges and sensory afferent signals. The dyspnea results from an imbalance between the intensity of the central respiratory command and the information given by the respiratory sensors coming from the lung, chest wall, respiratory muscles, airways and central and peripheral chemoreceptors. A copy of motor information from the motor cortex or the brainstem is projected onto the somatosensory cortex. Imbalance between corollary discharges (effort) and afferent signals is treated in the limbic system and leads to the sensation of dyspnea. BRC, brainstem respiratory center; MN, motor neuron relay.
dyspnea [23] , none of them is ideal for critically ill patients. If the patient can point to a line, we recommend the use of the D-VAS, which is the gold standard in the general population and ensures a more precise continuous measure of dyspnea intensity [1] . An alternative is to use the 0-10 Numeric Rating Scale (NRS), which consists in determining either verbally (between 0 and 10) or visually (on vertical or horizontal scale ranging from 0 to 10), which value corresponds to the patient's dyspnea intensity [24] . In patients who cannot associate numeric values to their symptoms, the modified dyspnea Borg scale (D-Borg) [25] might be used. It consists of verbal descriptors linked to specific numbers, in which the spacing of the numbers and corresponding descriptors essentially provides a category scale with ratio properties. This scale ranges from 0, representing no dyspnea, to 10, representing maximal dyspnea.
Clinically significant dyspnea is usually defined as D-VAS or D-NRS at least 4, and 'somewhat severe dyspnea' on modified Borg scale [5,6,7,9 && ,26]. First, such value corresponds to the lower quartile of dyspnea ratings in ICU patients experiencing dyspnea [5, 6] . Second, a D-NRS at least 4 corresponds to a 'moderate intensity' when compared with verbal descriptors [27] . Third, by analogy with pain, a VAS or NRS at least 4 is also the lower threshold for 'moderate-to-severe pain' and constitute a clear indication for prompt analgesic prescription [28] . Fourth, D-NRS at least 4 in mechanically ventilated patients is associated with a higher risk of SBT failure [14] , NIV failure and hospital mortality [9 && ]. Thus, we consider that a dyspnea intensity at least 4 is a clinically relevant dyspnea that must encourage caregivers for therapeutic interventions aimed at reducing its intensity.
Detection of dyspnea in noncommunicative patients
One-third of critically ill patients are unable to selfreport sensations or symptoms [3] [4] [5] . Main reasons are ongoing sedation, delirium, language barrier or sensory deficiency, such as deafness. The fact that patients cannot communicate does not mean that they do not feel dyspnea and it is clear that these patients are exposed to the same risk factors of dyspnea than communicative patients [29] . Like observed with pain, it cannot be excluded that sedation, may give an external appearance of respiratory comfort, but falsely reassuring [30, 31] . Therefore, noncommunicative patients should rather be considered as a vulnerable population at high risk for misdiagnosis of dyspnea.
Unfortunately, it is demonstrated that caregivers markedly underestimate patient's dyspnea in the ICU. In two recent studies, physicians, respiratory therapists and nurses markedly underestimated the intensity of dyspnea reported by the patient [7,8 & ].
Heteroevaluation scales
To address this major issue, heteroevaluation scales of dyspnea based on physical and observable signs of respiratory distress are promising alternatives. The Respiratory Distress Observation Scale (RDOS) has been first developed in terminally ill patients and validated in noncommunicative patients allowing identification of near-to-death patients who may benefit from oxygen therapy aimed at alleviated respiratory distress [32] .
A version of this scale adapted to ICU patients, the Intensive Care -RDOS (IC-RDOS) has been developed [5] . This scale includes five observable items (Fig. 2) and is reliable in noncommunicative critically ill patients. An IC-RDOS of 2.4 predicts a D-VAS at least 4 with 72% sensitivity and 72% specificity. In mechanically ventilated patients, the Mechanical Ventilation -RDOS (MV-RDOS) is slightly more reliable to detect dyspnea than the IC-RDOS (Fig. 2) [33 
&&
].
Biomarkers of dyspnea
Two electrophysiological markers of dyspnea are currently validated in healthy volunteers and in patients: the electromyographic activity of the extradiaphragmatic inspiratory muscles [34] and the premotor inspiratory potentials detected on the electroencephalogram [35, 36] . Such biomarkers of dyspnea could help to detect and quantify dyspnea regardless of the patient's cooperation. Further research and development is needed.
The causes of dyspnea: physiopathology and risk factors
Extensive reviews on dyspnea physiology can be found elsewhere [1, 37, 38] . The neurophysiological basis of dyspnea involves both excitatory and inhibitory afferent inputs from sensory nerves as well as perception of motor commands, named the 'corollary discharge.' The corollary discharge is an efferent copy of the respiratory motor output sent to the sensitive cortex. The sense of respiratory motor output that results from this copy is distinct from sensations directly related to changes in muscle length or tension. As illustrated in the Fig. 3 , in eupneic breathing, the corollary discharge (perception of motor command/sense of effort) is proportional to the afferent inputs. Dyspnea occurs as soon as there is an imbalance between the corollary motor discharge and the sensory peripheral response of the respiratory system.
In mechanically ventilated patients, dyspnea may results from a perception of the effort of breathing when the physical work of breathing is increased by an augmentation of respiratory muscle loading (i.e. increased resistance and decreased compliance), or when cortical motor drive is increased because of respiratory muscle weakness [39] . It can also result from the conscious perception of the need for more air that arises from stimulation of chemoreceptors (rise in PaCO 2 or a fall in PaO 2 ) [40] .
Finally, one of the most recent and striking developments in the field of pathophysiology of dyspnea is the recognition of the importance of the affective component of dyspnea. Both unpleasantness and emotional response can be differentially altered with different dyspnea modality or drug treatment [41] . Physiologically, the emotional component of dyspnea results from the cognitive-affective treatment of sensation, and is the basis of the corresponding short-term and long-term behavioral responses [42] , hence its probable importance in the genesis of posttraumatic stress disorders syndrome observed after certain stays in intensive care [43] .
To date, there is only 12 small sized, heterogeneous [6, 7, 8 & , 14, 25, [44] [45] [46] [47] [48] [49] [50] prospective studies on dyspnea in intubated patients. This is very few as compared with pain assessment [28] , but these have identified various risk factors for dyspnea.
From a more clinical standpoint, the main determinant of dyspnea is the respiratory and circulatory state of the patient [51] . Altered respiratory mechanics (elevated resistance and low compliance) and altered gas exchange (hypoxemia and hypercapnia) are a clear cause of dyspnea. Various nonspecific factors are susceptible to increase the ventilatory drive and cause dyspnea, such as anemia fever or acidosis. In addition, activities related to care, such as nurse activities, bed transfers, bathing [41] or positioning [52] may also cause dyspnea. This is obviously the case for procedures, such as tracheal suctioning, or fiberoptic bronchoscopy [4] .
However, inappropriate ventilator settings remain a leading cause of dyspnea in ICU patients: optimizing ventilator settings could reduce its intensity in 35% of patients exhibiting dyspnea [6] . The ACV mode is independently associated with dyspnea, especially when the inspiratory flow is less than 60 l/min. Conversely, proportional assisted ventilation [53] and neutrally adjusted ventilator assist [54] are associated with less dyspnea. Clearly recommended strategies of lowering sedation, and the use of low tidal volumes [55] even in the absence of severe lung disorders [56, 57] are likely to increase the risk of dyspnea onset.
Finally, anxiety in intubated patients is strongly and independently associated with dyspnea and may increase per-se the ventilatory drive and the risk of dyspnea [6] .
Management of dyspnea in intubated patients
Once dyspnea has been diagnosed, it is essential to have a step-by-step procedure to identify the cause of dyspnea and treat it in so far as this is possible (Fig. 4) .
First reduce nonrespiratory stimuli of respiratory drive As previously stated, many metabolic stimuli, such as fever or hyperthermia may increase the respiratory drive. We suggest that, when it is not possible, not advisable or not logical to increase achieved ventilation, factors, such as acidosis, hypoxia, hyperthermia, and anemia should be corrected [58] .
Minimize respiratory impedance and alterations of gas exchange Increased resistance or decreased compliance may promote both excessive effort and air hunger. When increased airway resistance is because of COPD or asthma, bronchodilators might be efficient. In the case of a reduced compliance because of a large pleural effusion, thoracocenthesis might be performed. In other cases, such as reduced pulmonary compliance because of pneumonia or a cardiogenic pulmonary edema, there is no other option than waiting for the benefit of the treatment of the causative disease.
Although is makes sense to avoid severe hypoxemia, robust data are lacking concerning thesymptomatic response of dyspnea to supplemental oxygen [59] .
Optimize ventilator settings
In patients receiving assist-controlled ventilation, the first step should be to evaluate the possibility of switching to a partial mode of assistance, such as pressure support ventilation. If the patient needs to stay in assist-controlled ventilation, then the inspiratory flow has to be optimized and increased to over 1 l/s. If the patient is ventilated in pressure support ventilation, then the pressure support level might be increased, but over distention should be avoided. Finally, in the case of an intrinsic positive end expiratory pressure (PEEP), the level of external PEEP might be set in order to compensate intrinsic PEEP, which is not always easy without invasive measurements.
Consider pharmacologic approach
If all the previous interventions have failed to decrease dyspnea, pharmacological approach might be considered. Opioids are the mainstay of pharmacological management of dyspnea with a clearly demonstrated effectiveness [60] . The dose of opioids required for treating dyspnea is not well established compared to the doses needed to treat acute pain. 'Low and slow' intravenous titration of an immediate-release opioid, repeated every 15 min, until the patient reports or displays relief seems reasonable [61] .
On the basis of current data, the use of nebulized diuretics for the management of dyspnea in terminally ill patients is still controversial and cannot be recommended [62] . Cannabinoid may be of potential interest, but more studies are required [63] . Given the strong interplay between anxiety and dyspnea, treating anxiety may reduce dyspnea, although the dose of anxiolytic should not depress respiratory drive [64] .
Nonpharmacologic intervention
As they have basically no toxicity, nonpharmacologic interventions have raised the interest of physicians. Various nonpharmacologic interventions to treat dyspnea, such as walking aids, distractive auditory stimuli, chest wall vibration, acupuncture/ acupressure, relaxation, neuroelectrical muscle stimulation, fans have been recently reviewed and their benefit is not so clear [61] .
A promising approach would be to modulate the emotional and affective component of dyspnea by a pleasant music or positive pictures [65] . The modulation of the sensorial component of dyspnea is another approach. In palliative care patients with refractory dyspnea, ventilator-associated air delivery is associated with a 30% decrease in dyspnea intensity [66] .
CONCLUSION
There is growing evidence suggesting that dyspnea is frequent and severe in mechanically ventilated ICU patients. In these patients, dyspnea is highly associated with anxiety and might be linked to a poorer outcome. Heteroevaluation scale will help caregivers to detect respiratory suffering in noncommunicative patients and tailor its treatment. Finally, the ventilator settings seem to be a major determinant of dyspnea.
Future large-scale studies are now needed. These studies should aim to quantify the prevalence of dyspnea in a very large population of patients through multicenter studies. They should also study the occurrence and the intensity of dyspnea on a longitudinal basis. This could allow physicians to know if dyspnea could be a monitoring tool that might predict an ongoing complication in an ICU patient. Finally, the long-term impact of dyspnea in ICU patients needs to be evaluated.
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